Summary:
Clinical Trials of Texas, Inc. is conducting a research study for people 18 and up with Type 1 Diabetes. The study will be comparing the safety and effectiveness of an investigational medication to Lantus™.
Qualified Participants Must:
• Be 18 years of age or older
•
Be diagnosed with Type 1 Diabetes for at least 1 year
•
Currently be using a short-acting insulin
•
Not be using an insulin pump
•
Additional criteria may apply
Qualified Participants May Receive:
Study related medication, tests and care from a board certified physician. Compensation up to to $480 will be available for time and travel.